Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rovin BH et al. – Data on adjusting therapy on the basis of pharmacogenetics/genomics and pharmacodynamics are summarized to demonstrate where the field is, and biomarker studies that reflect the future of personalized medicine are discussed. The goal of this review is to demonstrate that we can personalize therapy for kidney diseases but that considerable investment in new research will be required for personalized medicine to be routinely used in nephrology clinics.

Related Articles

Understanding Diabetes Mellitus And Kidney Disease
Nephrology Nursing Journal, 10/02/09    Relevance Score: 71%

Diabetic kidney disease in the older adult: an update
Aging Health, 10/07/09    Relevance Score: 70%

The Intersection of Geriatrics and Chronic Kidney Disease: Frailty and Disability Among Older Adults With Kidney Disease
Advances In Chronic Kidney Disease, 10/07/09    Relevance Score: 70%

Charcoal Treats Heart Disease
Ivanhoe, 11/05/09    Relevance Score: 69%

Can charcoal fight heart disease in kidney patients?
EurekAlert, 11/02/09    Relevance Score: 69%

Today in Radiology/Diagnostics...keeping you current

Foam sclerotherapy techniques: different gases and methods of preparation, catheter versus direct injection
Phlebology, 12/09/09

Magnetic Resonance Imaging in Lewy Body Dementias
Dementia and Geriatric Cognitive Disorders, 12/09/09

Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older men
BJU International, 12/09/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address